Synthace competitorsClear all

Synthace's top competitors include International Stem Cell Corporation, Clementia Pharmaceuticals, Sierra Oncology and DBV Technologies.
Synthace
Synthace
Synthace produces bio-based chemical products through the application of synthetic biology.
International Stem Cell Corporation
International Stem Cell Corporation
International Stem Cell Corporation is a biotechnology company focused on therapeutic and research products.
Clementia Pharmaceuticals
Clementia Pharmaceuticals
Clementia Pharmaceuticals develops and commercializes therapeutics for people suffering from rare diseases.
Sierra Oncology
Sierra Oncology
Sierra Oncology (formerly known as ProNAi Therapeutics) is a clinical stage drug development company.
DBV Technologies
DBV Technologies
We are committed to finding a safe, effective and patient-friendly therapy for food and pediatric allergy patients, for whom there are no currently approved treatments.
Founding Date
Founding Date
2011
Founding Date
2001
Founding Date
2012
Founding Date
2004
Founding Date
2002
Type
Type
Private
Type
Public
Type
Subsidiary
Type
Public
Type
Public
Tags
Locations
Locations
London, GB HQ
Locations
Carlsbad, US HQ
Frederick, US
Oceanside, US
Locations
Westmount, CA HQ
Newton, US
Locations
Vancouver, CA HQ
Daytona Beach, US
Kalamazoo, US
Locations
Montrouge, FR HQ
New York, US
Employees
Employees
767% increase
Employees
4814% increase
Employees
N/A
Employees
53
Employees
113
Valuation ($)
Valuation ($)
N/A
Valuation ($)
10 m
Valuation ($)
N/A
Valuation ($)
47.4 m
Valuation ($)
648.6 m
Twitter followers
Twitter followers
1.3 k
Twitter followers
9.1 k
Twitter followers
N/A
Twitter followers
112
Twitter followers
1.2 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
32
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
2
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
2.5
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
17.5
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
93.75%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Alexa Website Rank
Alexa Website Rank
636262
Alexa Website Rank
353253
Alexa Website Rank
1040544
Alexa Website Rank
702533
Alexa Website Rank
531322

Financial

Revenue (est.)
Revenue (est.)
£581 (FY, 2013)
Revenue (est.)
$11.1m (FY, 2018)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
€11.9m (FY, 2017)
Net income
Net income
(£361.6k) (FY, 2013)
Net income
($2.1m) (FY, 2018)
Net income
($57.5m) (FY, 2016)
Net income
N/A
Net income
(€147.7m) (FY, 2017)

Funding

Total funding raised
Total funding raised
$ 41.8m
Total funding raised
$ 7.5m
Total funding raised
$ 92.5m
Total funding raised
$ 74m
Total funding raised
$ 28.2m
For sources of this data, please see the company profile

View company profiles

International Stem Cell Corporation
HQ
Carlsbad, US
Employees
48↑ 14% increase

International Stem Cell Corporation is a biotechnology company focused on therapeutic and research products.

View company
Clementia Pharmaceuticals
HQ
Westmount, CA

Clementia Pharmaceuticals develops and commercializes therapeutics for people suffering from rare diseases.

View company
Sierra Oncology
HQ
Vancouver, CA
Employees
53

Sierra Oncology (formerly known as ProNAi Therapeutics) is a clinical stage drug development company.

View company
DBV Technologies
HQ
Montrouge, FR
Employees
113

We are committed to finding a safe, effective and patient-friendly therapy for food and pediatric allergy patients, for whom there are no currently approved treatments.

View company